Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

Jaattela, 1992, Emerging role of heat shock proteins in biology and medicine, Ann Med., 24, 249, 10.3109/07853899209149952 Jaattela, 1999, Escaping cell death: survival proteins in cancer, Exp Cell Res., 248, 30, 10.1006/excr.1999.4455 Garrido, 2001, Heat shock proteins: endogenous modulators of apoptotic cell death, Biochem Biophys Res Commun., 286, 433, 10.1006/bbrc.2001.5427 Bonay, 1994, Expression of heat shock proteins in human lung and lung cancers, Am J Respir Cell Mol Biol, 10, 453, 10.1165/ajrcmb.10.4.8136161 Malusecka, 2001, Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study, Anticancer Res, 2, 1015 Lehman, 1991, p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines, Cancer Res., 5, 4090 Beer, 2002, Gene-expression profiles predict survival of patients with lung adenocarcinoma, Nat Med., 8, 816, 10.1038/nm733 Palliser, 2001, Unraveling the mechanisms by which heat shock proteins activate the immune system, Curr Opin Mol Ther, 3, 25 Srivastava, 2001, Heat shock proteins: the ‘Swiss Army Knife’ vaccines against cancers and infectious agents, Vaccine, 19, 2590, 10.1016/S0264-410X(00)00492-8 Singh-Jasuja, 2001, The role of heat shock proteins and their receptors in the activation of the immune system, Biol Chem., 382, 629, 10.1515/BC.2001.074 Conroy, 1998, Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients, Eur J Cancer, 34, 942 Trieb, 2000, Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy, Br J Cancer, 82, 85, 10.1054/bjoc.1999.0881 Trieb, 2000, Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma, Immunobiology, 201, 368, 10.1016/S0171-2985(00)80091-1 Luo, 2002, Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library, Br J Cancer, 87, 339, 10.1038/sj.bjc.6600439 Ohguro, 1999, Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy, Invest Ophthalmol Vis Sci., 40, 82 Cardillo, 2000, Heat shock protein-90, IL-6 and IL-10 in bladder cancer, Anticancer Res., 20, 4579 Conroy, 1994, Detection of autoantibodies to the 90 kDa heat shock protein in systemic lupus erythematosus and other autoimmune diseases, Br J Rheumatol., 33, 923, 10.1093/rheumatology/33.10.923 Hayem, 1999, Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis, Ann Rheum Dis., 58, 291, 10.1136/ard.58.5.291 Rauch, 2000, Anti-heat shock protein 70 antibodies in Meniere’s disease, Laryngoscope, 110, 1516, 10.1097/00005537-200009000-00020 Prummel, 1997, Anti-heat shock protein (hsp) 72 antibodies are present in patients with Graves’ disease (GD) and in smoking control subjects, Clin Exp Immunol, 110, 292, 10.1111/j.1365-2249.1997.tb08330.x Pockley, 2002, Circulating heat shock protein and heat shock protein antibody levels in established hypertension, J Hypertens, 20, 1815, 10.1097/00004872-200209000-00027 Kocsis, 2002, Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease, Immunol Invest, 31, 219, 10.1081/IMM-120016242 Wright, 2000, Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease, Heart Vessels, 15, 18, 10.1007/s003800070043 Pashov, 2002, Autoantibodies to heat shock protein 90 in the human natural antibody repertoire, Int Immunol., 14, 453, 10.1093/intimm/14.5.453 Pockley, 1998, Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals, Immunol Invest., 27, 367, 10.3109/08820139809022710 Rea, 2001, Serum heat shock protein and anti-heat shock protein antibody levels in aging, Exp Gerontol., 36, 341, 10.1016/S0531-5565(00)00215-1 Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 25, 3389, 10.1093/nar/25.17.3389 Pujol, 2001, Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients, Lung Cancer, 31, 221, 10.1016/S0169-5002(00)00186-0 Wieskopf, 1995, Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role, Chest, 108, 163, 10.1378/chest.108.1.163 Kulpa, 2002, Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients, Clin Chem., 48, 1931, 10.1093/clinchem/48.11.1931 Vassilakopoulos, 2001, Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer, Lung Cancer, 32, 137, 10.1016/S0169-5002(00)00225-7 Nisman, 1998, Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma. Does the combined use of cytokeratin markers give any additional information?, Cancer, 82, 1850, 10.1002/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R Molina, 1994, CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels, Int J Biol Markers, 9, 96, 10.1177/172460089400900206 Lamb, 1989, Stress proteins may provide a link between the immune response to infection and autoimmunity, Int Immunol., 1, 191, 10.1093/intimm/1.2.191 Handley, 1996, Autoantibodies to human heat shock protein (hsp) 60 may be induced by Escherichia coli groEL, Clin Exp Immunol., 103, 429, 10.1111/j.1365-2249.1996.tb08298.x de Smet, 2001, Circulating antibodies to inducible heat shock protein 70 in patients with uveitis, Ocul Immunol Inflamm., 9, 85, 10.1076/ocii.9.2.85.3973 Vayssier-Taussat, 2001, Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses, Am J Physiol Heart Circ Physiol, 280, 1293, 10.1152/ajpheart.2001.280.3.H1293 Kaur, 1998, Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity, Oral Oncol, 34, 496, 10.1016/S1368-8375(98)00064-5 Volm, 1995, Up-regulation of heat shock protein 70 in adenocarcinomas of the lung in smokers, Anticancer Res, 15, 2607 Koomagi, 1996, Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer, Cancer Lett, 110, 129, 10.1016/S0304-3835(96)04471-0 Buccheri, 1986, Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma, Cancer, 57, 2389, 10.1002/1097-0142(19860615)57:12<2389::AID-CNCR2820571225>3.0.CO;2-# Mizushima, 1991, Clinical evaluation of five tumor marker assays in staging system for lung cancer, Anticancer Res, 11, 91